Skip to main content

NUEVOS AGENTES ANTIBACTERIANOS DE PRECISION Y TERAPIAS COMBINADAS PARA COMBATIR INFECCIONES MULTIRRESISTENTES

PID2022-136963OB-I00

•
Funding agency name Agencia Estatal de Investigación
Funding agency acronym AEI
Program Programa Estatal para Impulsar la Investigación Científico-Técnica y su Transferencia
Subprogram Subprograma Estatal de Generación de Conocimiento
Call Proyectos de I+D+i (Generación de Conocimiento y Retos Investigación)
Call year 2022
State Plan 2021-2023 Plan Estatal de Investigación Científica y Técnica y de Innovación
Beneficiary centre UNIVERSIDADE DE SANTIAGO DE COMPOSTELA

Resultados relacionados

Resultados totales (Incluyendo duplicados): 9
Encontrada(s) 1 página(s)

RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

Antimicrobial activity of essential oil components against Escherichia coli depends on the food components present in a food matrix

  • Gómez-Llorente, Héctor|||0000-0001-5968-6041
  • Pérez-Esteve, Édgar|||0000-0002-0452-1394
  • Barat Baviera, José Manuel|||0000-0001-8487-7114
  • Jiménez, M Consuelo|||0000-0002-8057-4316
  • Fernández Segovia, Isabel|||0000-0002-7641-2680
  • González-Bello, Concepción
[EN] Despite numerous studies evaluating the antimicrobial activity of essential oil components (EOCs) against different microorganisms, the effect of the composition of the matrix in which they are applied remains unexplored. Hence, the effect of different food components (i.e., proteins, lipids, carbohydrates, acids, ethanol) on vanillin antimicrobial activity was carried out by assessing the growth of E. coli at different incubation times (0, 1, 4, 8 and 24 h). Based on these outcomes, the food components that most adversely affected vanillin antimicrobial activity were subsequently tested with four other EOCs (i.e., carvacrol, eugenol, geraniol, thymol). The effective concentration of antimicrobials after coming into contact with food components was quantified. The results indicated that bovine serum albumin (BSA), sunflower oil and carbohydrates partially or completely inhibited the antimicrobial efficacy of the tested EOCs, and the inhibition rate depended on the specific EOC-food component combination. Geraniol was notably the most efficient with BSA present. Eugenol performed best with sunflower oil. Carvacrol, eugenol, geraniol and thymol were more effective than vanillin with D-lactose present. This study confirmed that loss of EOCs' effective concentration due to an interaction with food constituents is a significant cause of antimicrobial activity inhibition. These findings underscore the importance of considering matrix composition when selecting antimicrobials to combat a particular strain in real food applications., The authors gratefully acknowledge the financial support from the project PID2021-128141OB-C21 funded by MCIN/AEI/10.13039/501100011033 and by "ERDF A way of making Europe". This work is also granted by the project TED2021-132035B-I00, funded by MCIN/AEI/10.13039/501100011033 and by "European Union NextGenerationEU/PRTR". CG-B thanks the financial support received from the Spanish State Agency of Research (PID2022-136963OB-I00/AEI/10.13039/501100011033) , the Xunta de Galicia [ED431C 2021/29 and Centro singular de investigacion de Galicia accreditation 2023-2027 (ED431G 2023/03) ], and the European Regional Development Fund (ERDF). H.G.LL. acknowledges the Universitat Politecnica de Valencia for his predoctoral fellowship.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

Modulation of the photobehavior of gefitinib and its phenolic metabolites by human transport proteins

  • Tamarit-Mayo, Lorena
  • Andreu, Inmaculada|||0000-0003-3409-9443
  • Vayá Pérez, Ignacio|||0000-0003-1682-9342
  • El Ouardi, Meryem
  • Lence, Emilio
  • González-Bello, Concepción
  • Miranda Alonso, Miguel Ángel
[EN] The photobiological damage that certain drugs or their metabolites can photosensitize in proteins is generally associated with the nature of the excited species that are generated upon interaction with UVA light. In this regard, the photoinduced damage of the anticancer drug gefitinib (GFT) and its two main photoactive metabolites GFT-M1 and GFT-M2 in cellular milieu was recently investigated. With this background, the photophysical properties of both the drug and its metabolites have now been studied in the presence of the two main transport proteins of human plasma, i.e., serum albumin (HSA) and ¿1-acid glycoprotein (HAG) upon UVA light excitation. In general, the observed photobehavior was strongly affected by the confined environment provided by the protein. Thus, GFT-M1 (which exhibits the highest phototoxicity) showed the highest fluorescence yield arising from long-lived HSA-bound phenolate-like excited species. Conversely, locally excited (LE) states were formed within HAG, resulting in lower fluorescence yields. The reserve was true for GFT-M2, which despite being also a phenol, led mainly to formation of LE states within HSA, and phenolate-like species (with a minor contribution of LE) inside HAG. Finally, the parent drug GFT, which is known to form LE states within HSA, exhibited a parallel behavior in the two proteins. In addition, determination of the association constants by both absorption and emission spectroscopy revealed that the two metabolites bind stronger to HSA than the parent drug, whereas smaller differences were observed for HAG. This was further confirmed by studying the competing interactions between GFT or its metabolites with the two proteins using fluorescence measurements. These above experimental findings were satisfactorily correlated with the results obtained by means of molecular dynamics (MD) simulations, which revealed the high affinity binding sites, the strength of interactions and the involved amino acid residues. In general, the differences observed in the photobehavior of the drug and its two photoactive metabolites in protein media are consistent with their relative photosensitizing potentials., The Ministry of Science, Innovation and Universities of Spain, the Conselleria d'Innovacio, Universitats, Ciencia i Societat Digital, the University of Valencia, the Health Research Institute Hospital La Fe (IIS La Fe) and La Xunta de Galicia are gratefully acknowledged for financial support. All authors are grateful to the Centro de Supercomputacion de Galicia (CESGA) for use of the Finis Terrae computer.The author(s) declare that financial support was received for the research, authorship, and/or publication of this article. Grants PID2020-115010RB-I00 and PID2022-136963OB-I00 funded by MCIN/AEI/10.13039/501100011033, grant CIAICO/2021/061 funded by Conselleria d'Innovacio, Universitats, Ciencia i Societat Digital and grant AP2022-5 funded by Programa d'Accions Preparatories UV-La Fe. Grants from the Xunta de Galicia [ED431C 2021/29 and the Centro singular de investigacion de Galicia accreditation 2019-2022 (ED431G 2019/03), CG-B], and the European Regional Development Fund (ERDF).
Minerva. Repositorio Institucional de la Universidad de Santiago de Compostela
Publication Artículo científico (JournalArticle)

Zwitterionic penicillin-derived sulfone inhibitor for combating β-lactamase-mediated antibiotic resistance

  • Rodríguez Lema, Diana
  • Lence Quintana, Emilio José
  • Vázquez Ucha, Juan Carlos
  • Beceiro Casas, Alejandro
  • González Bello, Concepción
β-Lactam antibiotics, which account for nearly 70% of all prescriptions for bacterial infections, remain the cornerstone of antimicrobial chemotherapy. However, their clinical effectiveness is increasingly compromised by the widespread emergence of β-lactamase-mediated resistance. These enzymes hydrolyze the β-lactam ring through an addition–elimination mechanism, abolishing antibacterial activity. Preserving the efficacy of β-lactam antibiotics, particularly carbapenems, regarded as the last line of defense against multidrug-resistant (MDR) pathogens, is therefore critical. Here, we report the design and synthesis of compound 3, a zwitterionic penicillin-derived sulfone that integrates two key principles: enhanced permeability of zwitterionic molecules and improved inhibitory potency through (2-pyridyl)methylene introduction within the sulbactam scaffold to achieve an adduct stable against hydrolysis. In vitro assays demonstrated that compound 3 significantly restored β-lactam activity against MDR pathogens producing extended-spectrum β-lactamases (ESBLs) and carbapenem-hydrolyzing class D β-lactamases. It notably improved imipenem and ceftazidime efficacy against strains expressing OXA-48 and PDC-1, whose inhibitory capacity was determined by kinetic analysis with the isolated enzymes. Mechanistic studies using mass spectrometry and molecular dynamics simulations revealed ligand-induced pocket formation, π-stacking modulation, and hydrophobic engagement, supporting a covalent, water-shielded inactivation pathway via indolizine adduct formation. The nonsterically hindered amine in 3 favored PDC-1 binding and overall permeability while exerting a neutral effect on OXA-48 binding. These results underscore the potential of compound 3 as a next-generation β-lactamase inhibitor for combating infections caused by ESBL- and carbapenemase-producing Enterobacterales and Pseudomonas aeruginosa
Minerva. Repositorio Institucional de la Universidad de Santiago de Compostela
Publication Artículo científico (JournalArticle)

High-affinity A/T-rich DNA binding with a dimeric bisbenzamidine

  • Bouzada Reboredo, David
  • Paul, Ananya
  • Sánchez López, Mateo Isidro
  • Domínguez-Asenjo, Bárbara
  • Lence Quintana, Emilio José
  • Melle-Franco, Manuel
  • Ardá, Ana
  • Barreiro Piñeiro, Natalia
  • Penas, Cristina
  • Gómez González, Jacobo
  • Jiménez-Barbero, Jesús
  • Moreno, Javier
  • González Bello, Concepción
  • Wilson, W. David
  • Mascareñas Cid, José Luis
  • Vázquez Sentís, Marco Eugenio
A bisbenzamidine DNA binding agent can be easily dimerized by alkylation of its terminal amidine groups to afford an extended minor groove binder with over 20-fold enhanced DNA affinity toward extended A/T-rich sites. Nuclear magnetic resonance experiments in combination with molecular dynamics simulation studies provide structural insight into the insertion of this compound in the DNA minor groove, and antimicrobial assays demonstrate that the increased affinity translates into higher antileishmanial activity.
Minerva. Repositorio Institucional de la Universidad de Santiago de Compostela
Publication Artículo científico (JournalArticle)

Chemical sensors for the early diagnosis of bacterial resistance to β-lactam antibiotics

  • Canabal Falcón, Rafael
  • González Bello, Concepción
β-Lactamases are bacterial enzymes that inactivate β-lactam antibiotics and, as such, are the most prevalent cause of antibiotic resistance in Gram-negative bacteria. The ever-increasing production and worldwide dissemination of bacterial strains producing carbapenemases is currently a global health concern. These enzymes catalyze the hydrolysis of carbapenems – the β-lactam antibiotics with the broadest spectrum of activity that are often considered as drugs of last resort. The incidence of carbapenem-resistant pathogens such as Pseudomonas aeruginosa, Acinetobacter baumannii and carbapenemase or extended spectrum beta-lactamase (ESBL)-producing Enterobacterales, which are frequent in clinical settings, is worrisome since, in some cases, no therapies are available. These include all metallo-β-lactamases (VIM, IMP, NDM, SMP, and L1), and serine-carbapenemases of classes A (KPC, SME, IMI, and GES), and of classes D (OXA-23, OXA-24/40, OXA-48 and OXA-58). Consequently, the early diagnosis of bacterial strains harboring carbapenemases is a pivotal task in clinical microbiology in order to track antibiotic bacterial resistance and to improve the worldwide management of infectious diseases. Recent research efforts on the development of chromogenic and fluorescent chemical sensors for the specific and sensitive detection and quantification of β-lactamase production in multidrug-resistant pathogens are summarized herein. Studies to circumvent the main limitations of the phenotypic and molecular methods are discussed. Recently reported chromogenic and fluorogenic cephalosporin- and carbapenem-based β-lactamase substrates will be reviewed as alternative options to the currently available nitrocefin and related compounds, a chromogenic cephalosporin-based reagent widely used in clinical microbiology laboratories. The scope of these new chemical sensors, along with the synthetic approaches to synthesize them, is also summarized
Minerva. Repositorio Institucional de la Universidad de Santiago de Compostela
Publication Artículo científico (JournalArticle)

Advancements in the fight against globally distributed OXA-48 carbapenemase: evaluating the new generation of carbapenemase inhibitors

  • Outeda García, Michelle
  • Lence Quintana, Emilio José
  • González Bello, Concepción
  • Beceiro, Alejandro
Carbapenemase OXA-48 and its variants pose a serious threat to the development of effective effective effective treatments for bacterial infections. OXA-48-producing Enterobacterales are the most prevalent carbapenemase-producing bacteria in large parts of the world. Although these bacteria exhibit low-level carbapenem resistance in vitro, the infections they cause are challenging to treat with conventional therapies, owing to their spread and complex detection in clinical settings. However, numerous β-lactamase inhibitors (BLIs) are currently in the pipeline or late clinical stages. To assess the potential of these compounds, this study compared the efficacy efficacy against OXA-48 of novel β-lactamase inhibitors, specifically the 1,6-diazabicyclo[3,2,1]octanes (DBOs) avibactam, relebactam, zidebactam, nacubactam, and durlobactam, along with the cyclic and bicyclic boronates vaborbactam, taniborbactam, and xeruborbactam. The extensive kinetics assays identified identified xeruborbactam, taniborbactam, and durlobactam, together with the already established avibactam, as BLIs with superior biochemical performance. Susceptibility testing further validated these findings but also demonstrated significantly significantly significantlysignificantlyimproved bacterial killing by the DBOs zidebactam, nacubactam, and durlobactam. On the other hand, binding studies demonstrated the superior inhibitory capacity of the BLIs durlobactam and xeruborbactam. Combinations, such as cefepime/zidebactam, meropenem/nacubactam, and sulbactam/durlobactam, show promising activity against OXA-48-producing Enterobacterales, while ceftazidime/avibactam, cefepime/taniborbactam, and meropenem/xeruborbactam combinations also appear highly active, largely due to the excellent kinetics of these new inhibitors. Overall, this comprehensive analysis provides important insights into the effectiveness effectiveness effectiveness of new BLIs against OXA-48-producing Enterobacterales, highlighting xeruborbactam, durlobactam, and avibactam as leading candidates. Additionally, BLIs like zidebactam, nacubactam, and taniborbactam also showed potential in addressing the clinical challenges posed by OXA-48-mediated antimicrobial resistance.
Minerva. Repositorio Institucional de la Universidad de Santiago de Compostela
Publication Artículo científico (JournalArticle)

Novel antimicrobial self-assembled cyclic peptide nanotubes containing (1R,3S,4R,5R)-3-amino-4,5-dihydroxycyclohexane-1-carboxylic acid, a new building block for developing mimetics of saccharide–peptide hybrids

  • González Freire, Eva
  • Vilela Picos, Marcos
  • Prado López, Verónica
  • Pérez Estévez, Antonio
  • Seoane Prado, Rafael
  • Amorín López, Manuel
  • González Bello, Concepción
  • Granja Guillán, Juan Ramón
A new class of supramolecular antimicrobials based on D,L-cyclic peptides containing a dihydroxylated-γ-residue, which was designed to mimic the saccharide component present in certain carbohydrate–peptide hybrids, is described. The fully protected amino acid was prepared from shikimic acid and incorporated into clickable amphipathic cyclic peptides. The resulting peptides self-assemble into nanotubes that interact with bacterial membranes, ultimately causing cell death. Notably, the incorporation of this new residue not only retains antimicrobial activity but also significantly reduces toxicity in mammalian cells, thereby broadening the therapeutic window of these peptides.
Minerva. Repositorio Institucional de la Universidad de Santiago de Compostela
Publication Artículo científico (JournalArticle)

Antimicrobial activity of essential oil components against Escherichia coli depends on the food components present in a food matrix

  • Gómez-Llorente, Héctor
  • Pérez-Esteve, Édgar
  • Barat, José M.
  • Jiménez, M. Consuelo
  • González Bello, Concepción
  • Fernández-Segovia, Isabel
Despite numerous studies evaluating the antimicrobial activity of essential oil components (EOCs) against different microorganisms, the effect of the composition of the matrix in which they are applied remains unexplored. Hence, the effect of different food components (i.e., proteins, lipids, carbohydrates, acids, ethanol) on vanillin antimicrobial activity was carried out by assessing the growth of E. coli at different incubation times (0, 1, 4, 8 and 24 h). Based on these outcomes, the food components that most adversely affected vanillin antimicrobial activity were subsequently tested with four other EOCs (i.e., carvacrol, eugenol, geraniol, thymol). The effective concentration of antimicrobials after coming into contact with food components was quantified. The results indicated that bovine serum albumin (BSA), sunflower oil and carbohydrates partially or completely inhibited the antimicrobial efficacy of the tested EOCs, and the inhibition rate depended on the specific EOC-food component combination. Geraniol was notably the most efficient with BSA present. Eugenol performed best with sunflower oil. Carvacrol, eugenol, geraniol and thymol were more effective than vanillin with D-lactose present. This study confirmed that loss of EOCs’ effective concentration due to an interaction with food constituents is a significant cause of antimicrobial activity inhibition. These findings underscore the importance of considering matrix composition when selecting antimicrobials to combat a particular strain in real food applications.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Modulation of the photobehavior of gefitinib and its phenolic metabolites by human transport proteins

  • Tamarit, Lorena
  • El Ouardi, Meryem
  • Lence, Emilio
  • Andreu, Inmaculada
  • González-Bello, Concepción
  • Miranda, M. A.
  • Vayá, Ignacio
The photobiological damage that certain drugs or their metabolites can photosensitize in proteins is generally associated with the nature of the excited species that are generated upon interaction with UVA light. In this regard, the photoinduced damage of the anticancer drug gefitinib (GFT) and its two main photoactive metabolites GFT-M1 and GFT-M2 in cellular milieu was recently investigated. With this background, the photophysical properties of both the drug and its metabolites have now been studied in the presence of the two main transport proteins of human plasma, i.e., serum albumin (HSA) and α1-acid glycoprotein (HAG) upon UVA light excitation. In general, the observed photobehavior was strongly affected by the confined environment provided by the protein. Thus, GFT-M1 (which exhibits the highest phototoxicity) showed the highest fluorescence yield arising from long-lived HSA-bound phenolate-like excited species. Conversely, locally excited (LE) states were formed within HAG, resulting in lower fluorescence yields. The reserve was true for GFT-M2, which despite being also a phenol, led mainly to formation of LE states within HSA, and phenolate-like species (with a minor contribution of LE) inside HAG. Finally, the parent drug GFT, which is known to form LE states within HSA, exhibited a parallel behavior in the two proteins. In addition, determination of the association constants by both absorption and emission spectroscopy revealed that the two metabolites bind stronger to HSA than the parent drug, whereas smaller differences were observed for HAG. This was further confirmed by studying the competing interactions between GFT or its metabolites with the two proteins using fluorescence measurements. These above experimental findings were satisfactorily correlated with the results obtained by means of molecular dynamics (MD) simulations, which revealed the high affinity binding sites, the strength of interactions and the involved amino acid residues. In general, the differences observed in the photobehavior of the drug and its two photoactive metabolites in protein media are consistent with their relative photosensitizing potentials., The author(s) declare that financial support was received for the research, authorship, and/or publication of this article. Grants PID2020-115010RB-I00 and PID2022-136963OB-I00 funded by MCIN/AEI/10.13039/501100011033, grant CIAICO/2021/061 funded by Conselleria d’Innovació, Universitats, Ciència i Societat Digital and grant AP2022-5 funded by Programa d'Accions Preparatòries UV-La Fe. Grants from the Xunta de Galicia [ED431C 2021/29 and the Centro singular de investigación de Galicia accreditation 2019-2022 (ED431G 2019/03), CG-B], and the European Regional Development Fund (ERDF).